Introduction

PDF / 46,774 Bytes
2 Pages / 584.957 x 782.986 pts Page_size
62 Downloads / 470 Views

Introduction Guest Editors: Venkatesan Renugopalakrishnan, Ph.D. Children’s Hospital, Harvard Medical School and Northeastern University, Boston, MA, USA

Pulickel M. Ajayan, Ph.D. Rice University, Houston, TX, USA

Dorian Liepmann, Ph.D. University of California, Berkeley, CA, USA

Catherine Klapperich, Ph.D. Boston University, Boston, MA, USA

Sowmya Viswanathan, M.D. Newton Wellesley Hospital/Partners Healthcare System, Newton, MA, USA

Biomolecules functionalized on the surface of atomic thickness single layer 2D materials combine the exceptional electronic properties and the stereospeciﬁcity of host and guest molecular entities. However, it is a challenge to functionalize biomolecules retaining their 3D structural integrity after deposition or conjugation to the surface of a 2D nanomaterial. Engineering the interface between electronic materials and biomolecules is critical in integrating functional bio-inspired devices and realizing new technologies like in vitro Point-of-Care (POC) sensors for disease detection and monitoring. Much more challenging are sensors for implantation into living systems. The electronic characteristics of graphene are highly sensitive to adsorbed or covalently linked molecules via chemical doping. Inspired by biology, DNA, RNA, and proteins have been designed that spontaneously form exquisite molecular architectures on solid surfaces by self-assembly dictated by intermolecular forces. There are several facets of the integration of graphene and biomolecules like DNA that require much more understanding. Deeper understanding of these interfaces will enable engineers to bridge medical science and materials science in a meaningful way. Speciﬁc applications involve designing smart -POC devices for personalized precision medicine. Biosensors and POC devices for monitoring of multiple biomarkers, implantable devices, and non-invasive monitoring systems have signiﬁcantly improved in accuracy over the last twenty years. A good example is glucose sensors, which have been developed and reﬁned signiﬁcantly for over ﬁve decades. However, even with substantial effort, there continue to be several challenges

DOI: 10.1557/jmr.2017.305

related to accuracy and reliability. In accordance with international standards, glucometers are required to produce results within a twenty percent margin of error, and the U.S. Food and Drug Administration (FDA) is contemplating even more stringent standards. For this reason, coupled with knowledge gained from the previous research on glucose measurement, the ability to combine the exceptional electrical properties of emerging nanomaterials, both carbon and non-carbon-based, with the stereospeciﬁc functionality of biological macromolecules offers promising new avenues in diagnosis and treatment. Multiplexed lab-on-a-chip microﬂuidic devices designed by integrating graphene and other emerging nanomaterials that can sense and detect target biomarkers can exploit the full potential of proteins acting as nanosensors and nanoﬁlters. The excellent electrical properties

Data Loading...